PUBLICATIONS : CLINICAL RESEARCH

BASIC SCIENCE RESEARCH / CLINICAL RESEARCH / HIGH ALTITUDE MEDICINE RESEARCH

Lee WT, Brown A, Peacock AJ, Johnson MK. Use of non-invasive haemodynamic measurements to detect treatment response in precapillary pulmonary hypertension. Thorax 2011;66:810-4
McLure LE. Brown A. Lee WN. Church AC. Peacock AJ. Johnson MK. Non-invasive stroke volume measurement by cardiac magnetic resonance imaging and inert gas rebreathing in pulmonary hypertension. Clinical Physiology & Functional Imaging 2011; 31:221-6
Lee WT. Kirkham N. Johnson MK. Lordan JL. Fisher AJ. Peacock AJ. Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension. European Respiratory Journal 2011; 37:472-4
Lee WT. Peacock AJ. Johnson MK. The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension. European Respiratory Journal 2010 ; 36:1294-301
Church AC. Sanabria D. Peacock A. Johnson M. Epoprostenol use in a National Pulmonary Hypertension Centre from 1997 to 2007. Thorax 2009; 64:642
McLure LE. Peacock AJ. Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension. European Respiratory Journal 2009; 33:1454-66
Johnson MK, Lee WN, Sproule MW, Peacock AJ. Regional variations in pulmonary endarterectomy rates within the UK. European Respiratory Journal 2009; 33:453-4
Syyed R, Reeves JT, Welsh D, Raeside D, Johnson MK, Peacock AJ. The relationship between the components of pulmonary artery pressure remains constant under all conditions in both health and disease Chest 2008;133:633-9.
McLure LER, Peacock AJ. Imaging of the heart in pulmonary hypertension. International Journal of Clinical Practice 2007;Supplement.:15-26.
Blyth KG, Syyed R, Chalmers J, Foster JE, Saba T, Naeije R, Melot C, Peacock AJ. Pulmonary arterial pulse pressure and mortality in pulmonary arterial hypertension. Respiratory Medicine 2007;101:2495-501.
Peacock AJ, Murphy NF, McMurray JJV, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. European Respiratory Journal 2007;30:104-9.
Blyth KG, Groenning BA, Mark PB, Martin TN, Foster JE, Steedman T, Morton JJ, Dargie HJ, Peacock AJ. NT-proBNP can be used to detect RV systolic dysfunction in pulmonary hypertension. European Respiratory Journal 2007 (Epub 17135528)
Peacock A, Simonneau G, Rubin L. Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension. Proceedings of the American Thoracic Society 2006;3:608-14.
Peacock AJ. Pulmonary hypertension after splenectomy: a consequence of loss of the splenic filter or is there something more?. Thorax 2005;60:983-4.
Blyth KG, Groenning BA, Martin TN, Foster JE, Mark PB, Dargie HJ et al. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. European Heart Journal 2005;26:1993-9.
Peacock A, Naeije R, Galie N, Reeves JT. End points in pulmonary arterial hypertension: the way forward. European Respiratory Journal 2004;23:947-53.
Peacock AJ, National Pulmonary Hypertension Services of UK and Ireland. Treatment of pulmonary hypertension. BMJ 2003;326:835-6.
Raeside DA, Brown A, Patel KR, Welsh D, Peacock AJ. Ambulatory pulmonary artery pressure monitoring during sleep and exercise in normal individuals and patients with COPD. Thorax 2002;57:1050-3.
Saba TS, Foster J, Cockburn M, Cowan M, Peacock AJ. Ventricular mass index using magnetic resonance imaging accurately estimates pulmonary artery pressure. European Respiratory Journal 2002;20:1519-24.
Saba T, Peacock AJ. Long-term treatment of pulmonary hypertension with aerosolized iloprost.[comment]. European Respiratory Journal 2001;18:247.
Raeside DA, Smith A, Brown A, Patel KR, Madhok R, Cleland J et al. Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension. European Respiratory Journal 2000;16:282-7.
Egermayer P, Peacock AJ. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. European Respiratory Journal 2000;15:440-8.
Peacock AJ. Primary pulmonary hypertension. Thorax 1999;54:1107-18.
Brij S, Peacock AJ. Pulmonary hypertension: its assessment and treatment. Thorax 1999;54 Suppl 2:S28-S32.
Raeside DA, Chalmers G, Clelland J, Madhok R, Peacock AJ. Pulmonary artery pressure variation in patients with connective tissue disease: 24 hour ambulatory pulmonary artery pressure monitoring. Thorax 1998;53:857-62.
Raeside D, Peacock A. Making measurements in the pulmonary circulation: when and how? Thorax 1997;52:9-11.
Peacock AJ. Commentary: unusual causes of pulmonary hypertension. Thorax 1997; 52:1013.
Menon N, McAlpine L, Peacock AJ, Madhok R. The acute effects of prostacyclin on pulmonary hemodynamics in patients with pulmonary hypertension secondary to systemic sclerosis. Arthritis & Rheumatism 1998;41:466-9.
Peacock A. Vasodilators in pulmonary hypertension. Thorax 1993;48:1196-9.